Tag: neuroendocrine tumors
Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging Patient Program
Josh Mailman, President of the NorCal CarciNET support group and Chair of the Patient Advocate Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day …
READ MORE
Excel Diagnostics and Nuclear Oncology Center Selected For New Investigational PRRT Treatment and Gallium Scan for Carcinoid and Neuroendocrine Tumor Patients
For carcinoid, pancreatic neuroendocrine tumor, and other NET cancer patients seeking the most advanced nuclear medicine opportunities in the United States, Excel Diagnostics and Nuclear Oncology Center in Houston, Texas, in collaboration with…
READ MORE
New OncLive TV Series Focuses on Neuroendocrine Tumors
Carcinoid and neuroendocrine tumors (NETs), including pancreatic neuroendocrine tumors and even more uncommon NETs such as goblet cell carcinoid and mixed adenocarcinomas, are discussed by a panel of medical experts in this new video series from …
READ MORE
Carcinoid Research Fund — Please Vote for Louisiana State University Health Science Center Foundation (LSUHSC)
Your vote is needed to further carcinoid research! Ten local charities will be awarded $50,000 by the Gulf Coast Bank through its Community Rewards program. The LSUHSC Foundation — Carcinoid Research Fund (the NOLA Dream Team!) is one of the charities…
READ MORE
Unique Lung Carcinoid Conference to Feature European and American Physicians
When Dr. Dan Granberg, a leading carcinoid and neuroendocrine cancer specialist at Uppsala University in Sweden, joins Dr. Eric H. Liu, Director of the Neuroendocrine Tumor Center at Vanderbilt University Medical Center in Nashville, Tennessee, …
READ MORE
Luncheon with the Experts — Carcinoid and Neuroendocrine Tumor Patients Are Invited!!
The Big Apple Noids support group has initiated and is sponsoring, in collaboration with the Carcinoid Cancer Foundation, Luncheon with the Experts, a program which brings together carcinoid and neuroendocrine tumor (NET) patients with physicians…
READ MORE
Happy New Year from the Carcinoid Cancer Foundation
As 2012 draws to a close, the Carcinoid Cancer Foundation would like to thank each of you for your support. This year has been especially exciting because of our work on the Worldwide NET Cancer Awareness Day Alliance, with Grace Goldstein, CCF’s Chief…
READ MORE
Lexicon Pharmaceuticals Begins Phase 3 Clinical Trial of Telotristat Etiprate in Patients with Carcinoid Syndrome
Patients with metastatic carcinoid syndrome will have the opportunity to participate in a new Phase 3 clinical trial of Lexicon Pharmaceutical’s telotristat etiprate (LX1032), an oral drug candidate designed to treat carcinoid syndrome by reducing…
READ MORE
Carcinoid Cancer Foundation Participates in #GivingTuesday
Help launch #GivingTuesday™!! The Carcinoid Cancer Foundation is proud to participate in the first annual #GivingTuesday™ to be held on Tuesday, November 27, 2102. Charities, families, businesses and individuals are coming together to transform…
READ MORE
Neuroendocrine Tumor Webinar Just Opened to Patients and the Public
Just opened to the patient community and the public, with limited space available, is a free live webinar featuring carcinoid and NET cancer specialist Dr. Eric Liu, Director of the Neuroendocrine Center at Vanderbilt University Medical Center in Nashville,…
READ MORE
